Literature DB >> 25874419

Do concentrations of pharmaceuticals in sewage reflect prescription figures?

Alexander L N van Nuijs1, Adrian Covaci, Herman Beyers, Lieven Bervoets, Ronny Blust, Gert Verpooten, Hugo Neels, Philippe G Jorens.   

Abstract

In recent years, it has been demonstrated that sewage-based epidemiology can deliver interesting information on trends in illicit drug consumption. However, until now, no real evidence exists that the measured concentrations of drugs in sewage can be exactly correlated with the amounts of drugs used by a specific population. This study aimed therefore at correlating detailed monthly prescription figures of 11 pharmaceuticals (atenolol, bisoprolol, citalopram, fluoxetine, venlafaxine, losartan, telmisartan, valsartan, carbamazepine, metformin, and tramadol) with measured concentrations of these compounds in influent sewage from five sewage treatment plants in Belgium. For 7 out of the 11 substances, a ratio between loads calculated from the prescription figures and loads calculated from measured concentrations in the range of 0.30-3.00 was observed. For four pharmaceuticals (atenolol, bisoprolol, telmisartan, and venlafaxine), the observed relationship was less pronounced. The manuscript gives an overview of the possible uncertainties that are related with the calculated correlations. This study highlights the need for gathering all the necessary information regarding sewage sampling, stability of substances in sewage, pharmacokinetics, and analytical method performance when sewage-based epidemiology studies are performed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25874419     DOI: 10.1007/s11356-014-4066-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  24 in total

Review 1.  Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.

Authors:  B Huerta; S Rodríguez-Mozaz; D Barceló
Journal:  Anal Bioanal Chem       Date:  2012-06-08       Impact factor: 4.142

Review 2.  Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review.

Authors:  Christoph Ort; Michael G Lawrence; Jörg Rieckermann; Adriano Joss
Journal:  Environ Sci Technol       Date:  2010-08-15       Impact factor: 9.028

Review 3.  Environmental mass spectrometry: emerging contaminants and current issues.

Authors:  Susan D Richardson
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

4.  Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage.

Authors:  Marta Carballa; Francisco Omil; Juan M Lema
Journal:  Chemosphere       Date:  2008-06-02       Impact factor: 7.086

Review 5.  Water analysis: emerging contaminants and current issues.

Authors:  Susan D Richardson; Thomas A Ternes
Journal:  Anal Chem       Date:  2011-06-15       Impact factor: 6.986

6.  Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.

Authors:  Foon Yin Lai; Christoph Ort; Coral Gartner; Steve Carter; Jeremy Prichard; Paul Kirkbride; Raimondo Bruno; Wayne Hall; Geoff Eaglesham; Jochen F Mueller
Journal:  Water Res       Date:  2011-06-15       Impact factor: 11.236

7.  Testing wastewater to detect illicit drugs: state of the art, potential and research needs.

Authors:  Sara Castiglioni; Kevin V Thomas; Barbara Kasprzyk-Hordern; Liesbeth Vandam; Paul Griffiths
Journal:  Sci Total Environ       Date:  2014-07-15       Impact factor: 7.963

Review 8.  Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing.

Authors:  John M Brausch; Kristin A Connors; Bryan W Brooks; Gary M Rand
Journal:  Rev Environ Contam Toxicol       Date:  2012       Impact factor: 7.563

9.  Different compositions of pharmaceuticals in Dutch and Belgian rivers explained by consumption patterns and treatment efficiency.

Authors:  Thomas L ter Laak; Pascal J F Kooij; Harry Tolkamp; Jan Hofman
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-29       Impact factor: 4.223

10.  The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology?

Authors:  Alexander L N van Nuijs; Karim Abdellati; Lieven Bervoets; Ronny Blust; Philippe G Jorens; Hugo Neels; Adrian Covaci
Journal:  J Hazard Mater       Date:  2012-04-21       Impact factor: 10.588

View more
  4 in total

1.  Pharmaceuticals released from senior residences: occurrence and risk evaluation.

Authors:  Silvia Lacorte; Silvia Luis; Cristian Gómez-Canela; Teresa Sala-Comorera; Audrey Courtier; Benoit Roig; Ana Maria Oliveira-Brett; Claire Joannis-Cassan; Juan Ignacio Aragonés; Lucia Poggio; Thierry Noguer; Luisa Lima; Carlos Barata; Carole Calas-Blanchard
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-27       Impact factor: 4.223

2.  Occurrence of diazepam and its metabolites in wastewater and surface waters in Beijing.

Authors:  Congcong Wang; Linlin Hou; Jing Li; Zeqiong Xu; Tingting Gao; Jun Yang; Huafang Zhang; Xiqing Li; Peng Du
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-15       Impact factor: 4.223

3.  Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).

Authors:  Daniel J Duarte; Gunnar Niebaum; Volker Lämmchen; Eri van Heijnsbergen; Rik Oldenkamp; Lucia Hernández-Leal; Heike Schmitt; Ad M J Ragas; Jörg Klasmeier
Journal:  Environ Toxicol Chem       Date:  2021-05-28       Impact factor: 4.218

4.  Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.

Authors:  Jose Antonio Baz-Lomba; Stefania Salvatore; Emma Gracia-Lor; Richard Bade; Sara Castiglioni; Erika Castrignanò; Ana Causanilles; Felix Hernandez; Barbara Kasprzyk-Hordern; Juliet Kinyua; Ann-Kathrin McCall; Alexander van Nuijs; Christoph Ort; Benedek G Plósz; Pedram Ramin; Malcolm Reid; Nikolaos I Rousis; Yeonsuk Ryu; Pim de Voogt; Jorgen Bramness; Kevin Thomas
Journal:  BMC Public Health       Date:  2016-10-01       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.